Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Peg-Ginase 3750 IU Injection
Manufacturer/Marketed By : Celon Laboratories Pvt Ltd
$407.98 $246.85
Sidmex Inovia offers bulk export supply of Peg-Ginase 3750 IU Injection (Peg L-Asparaginase 3750 IU) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents,...
Peg L-Asparaginase 3750 IU
Active Pharmaceutical Ingredient
Peg-Ginase 3750 IU Injection
$407.98
$246.85
Sidmex Inovia offers bulk export supply of Peg-Ginase 3750 IU Injection (Peg L-Asparaginase 3750 IU) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Peg-Ginase 3750 IU Injection is an essential treatment option for various types of blood cancers, including Hodgkin's lymphoma, providing a targeted approach to combat these diseases. This injectable medication works by breaking down a specific amino acid, which cancer cells often rely on for growth and survival, thereby inhibiting their proliferation. Typically administered alongside other chemotherapeutic agents, Peg-Ginase enhances the overall effectiveness of the treatment regimen. Patients should be aware of potential side effects, which may include allergic reactions and changes in liver function, so close monitoring by healthcare professionals is crucial. It is important to discuss your complete medical history with your doctor before starting this therapy, as certain conditions may affect its suitability for you. Peg-Ginase represents a vital component in the fight against blood cancers, offering hope for improved patient outcomes. Always consult your healthcare provider for personalized advice and to understand how this medication fits into your overall treatment plan. By utilizing Peg-Ginase, patients may experience a more comprehensive approach to managing their cancer journey.
Active Pharmaceutical Ingredient
Uses
• Peg ginase 3750 iu injection is primarily used in the management of acute lymphocytic leukaemia (ALL). This medication aids in the reduction of cancerous cells in the blood and bone marrow. By targeting specific pathways involved in cell growth, Peg ginase 3750 iu injection helps to improve patient outcomes. It is often utilized in combination with other therapies to enhance its effectiveness.
• Non-Hodgkin's lymphoma (NHL) is another condition treated with Peg ginase 3750 iu injection. This injection assists in controlling the proliferation of malignant lymphocytes. Patients undergoing treatment for NHL may benefit from Peg ginase 3750 iu injection as part of their overall treatment regimen. It is designed to help manage symptoms and improve the quality of life.
• Peg ginase 3750 iu injection is beneficial for patients who have not responded adequately to other treatments for blood cancers. Its unique mechanism of action makes it suitable for those requiring alternative therapeutic options. Clinicians may recommend Peg ginase 3750 iu injection to help achieve better disease control. This can be particularly important in cases where traditional therapies have been ineffective.
• In certain cases, Peg ginase 3750 iu injection is used in conjunction with other anticancer medications. This combination approach can provide a more comprehensive treatment plan for patients with acute lymphocytic leukaemia or non-Hodgkin's lymphoma. By integrating Peg ginase 3750 iu injection, healthcare providers aim to maximize therapeutic benefits. This strategy often leads to improved treatment responses and patient satisfaction.
Benefits
Blood cancer (acute lymphocytic leukemia): Blood cancer, known as leukemia, is a malignancy that affects the blood-forming tissues and impairs the body's immune response to infection. Administration of Peg-Ginase 3750 IU Injection inhibits the proliferation of cancer cells and effectively eradicates them. This Peg-Ginase 3750 IU Injection has significant potency and toxicity, so a thorough discussion with your doctor regarding its potential risks and benefits is necessary. It is important to avoid alcohol during this treatment and to ensure adequate hydration by drinking plenty of water. Non-Hodgkin's lymphoma (NHL): Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is a part of the body's germ-combating immune system. Administration of Peg-Ginase 3750 IU Injection inhibits the proliferation of cancer cells and effectively eradicates them. This medication has significant potency and toxicity, so a thorough discussion with your doctor regarding its potential risks and benefits is necessary. It is important to avoid alcohol during this treatment and to ensure adequate hydration by drinking plenty of water.
Side Effects
Like all medicines, Peg-Ginase 3750 IU Injection may cause side effects that do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Nausea
• Vomiting
• Weakness
• Loss of appetite
• Diarrhoea
• Epigastric pain
• Swelling over hands/ feet and ankles
• Injection site reaction ( like pain, redness, swelling)
• Irritability
Common Side Effects
• Drowsiness
• Acute Pancreatitis ( Pain in abdomen, unable to eat, swollen and tender abdomen, Rapid pulse)
• Headache
• Tiredness
• Irritability
• Stomach cramps
• Weight loss
How To Use
Peg-Ginase 3750 IU Injection is available in liquid form (injectable) for IM and IV use, which should be administered by a healthcare professional under medical supervision. The dosage and frequency of administration will be determined by your physician based on your medical condition and many other factors. Peg-Ginase 3750 IU Injection should not be self-administered.
Safety Advice
• Alcohol: Drinking alcohol while taking Peg-Ginase 3750 IU is generally not recommended. It may increase the risk of liver damage and it is best to avoid alcohol or to limit the amount of alcohol you drink while you are taking this medicine.
• Kidney: For patients with kidney impairment, dose adjustment is not recommended. Peg-Ginase 3750 IU Injection has not been studied in patients with severe renal impairment or in patients who are undergoing peritoneal dialysis or haemodialysis.
• Breastfeeding: Breastfeeding while taking Peg-Ginase 3750 IU Injection is not recommended as it may be harmful to the baby. The constituents of Peg-Ginase 3750 IU can potentially pass into breast milk and pose a risk to the baby. If you are currently breastfeeding and using Peg-Ginase Injection, it is important to discuss the potential benefits and risks of continuing to breastfeed with your doctor. Your doctor will be able to advise you on how to ensure the optimum health of both you and your baby.
• Liver: For patients with mild liver disease, Peg-Ginase 3750 IU Injection is recommended. No dose adjustment is required in patients with mild liver impairment. However, Peg-Ginase 3750 IU is not recommended for use in patients with moderate or severe liver disease.
• Pregnancy: The use of Peg-Ginase 3750 IU Injection is not recommended in pregnant women as it may cause harm to the foetus if administered to a pregnant woman.
• Driving: It is uncommon for Peg-Ginase 3750 IU Injection to affect your driving skills.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.